The cannabis industry is one of the most exciting, controversial, and financially lucrative industries in the world today. The cannabis business can be broken down into several important categories: 1) the growing of the plant (or cultivation as it is often called), 2) the extraction of the oil, and 3) the sale of the finished and refined products. Each of these aspects of the cannabis industry is important, as each plays a vital role in the industry as a whole.
A similar story as with the group of companies that created the Groupon website, the many of the investors that invested in Pot Stock Earning $100 Million of Revenue per Month?
The above title is not a typo, as the blog post you are about to read shows just how profitable a marijuana stock can be, even in today’s market. The blog post you are reading was written about “Marquis Analytics”, which is a publicly traded company listed on the Canadian Stock Exchange that trades under the ticker symbol MDZ. At current market prices, Marquis has a market capitalization of $10,000,000,000 (One Hundred Billion Dollars) per share, making it the 26th most valuable company in the world. Since going public, the company has earned $100,000,000,000 (One Hundred Billion Dollars) in revenue. This is equivalent to a $100 million per month revenue stream!
The best choice for investors in potash
OTC stocks don’t have the best reputation. The idea is that if an American company is strong enough, it gets listed on the New York Stock Exchange (NYSE) or Nasdaq. While this impression is often correct, it does not fully apply to cannabis businesses. Given the current state of legislation in the US, many US marijuana companies prefer to list their shares on Canadian exchanges. As a result, its shares can only be traded on the over-the-counter market in the United States. Of course, some stocks are listed on the New York Stock Exchange or Nasdaq. But if you ignore the over-the-counter names in the marijuana industry, you could be missing out on great opportunities. For example, take a look at Curaleaf Holdings Inc (CNSX:CURA, OTCMKTS:CURLF). It is a vertically integrated cannabis operator headquartered in Wakefield, Massachusetts. The company has 23 cultivation facilities, more than 30 processing facilities, a retail network of 106 pharmacies and nearly 2,000 points of sale through its wholesale operations. Curaleaf operates in 23 states across the country and reaches 192 million people. (Source: the world’s largest cannabis company, Curaleaf Holdings Inc, last visited May 17, 2021). The company owns two of the best-known marijuana brands in the United States: Curaleaf for wellness products and Select for leisure products. Curaleaf is also moving internationally. With the recently completed acquisition of EMMAC Life Sciences Limited, Curaleaf is the first US multi-state cannabis operator with a significant presence in Europe. Like many US cannabis companies, Curaleaf Holdings Inc. is listed on the Canadian Securities Exchange – its stock symbol is CURA. In the United States, Curaleaf’s shares are traded in the over-the-counter market under the symbol CURLF. Like I said, it usually looks like OTC stocks are weak. But Curaleaf is a very strong company in its sector. You only have to look at their latest profit and loss statement to see what I mean. In the first quarter of 2021, Curaleaf generated $260.0 million in revenue, up 170% from the previous year and a new record for the company. This amount is higher than management’s previous forecast of $250.0 million to $255.0 million. (Source: Curaleaf reports record financial and operating results for Q1 2021, Curaleaf Holdings Inc, May 10, 2021). Revenues are up in a big way: Curaleaf retail sales rose 231% year-on-year and wholesale sales 254% year-on-year. The company also reported record adjusted earnings before interest, taxes, depreciation and amortization (EBITDA) for the quarter. This amount of $63.0 million was more than three times Curaleaf’s adjusted EBITDA of $20.0 million for last year’s period. And the best is probably yet to come. On the company’s recent conference call, Boris Jordan, executive chairman of Curaleaf Holdings Inc: … we are raising our expectations for the second quarter to $305 million to $315 million, which is above consensus based on our business performance in April [and] early May. (Source: Curaleaf Holdings, Inc (CURLF) Joe Bayern, CEO, on Q1 2021 results – Transcript of earnings conference call, Seeking Alpha, May 10, 2021). He continued: As a result, we remain on track to achieve our full year [IFRS] revenue forecast of $1.2 billion to $1.3 billion and an adjusted EBITDA margin of approximately 30%. Think about it. In today’s U.S. cannabis industry, a company with quarterly sales in excess of $100 million could be considered one of the industry’s heavyweights. Curaleaf expects revenues in the second quarter to be between $305.0 million and $315.0 million. That’s about $100 million in revenue per month!
Curaleaf Holdings Inc (OTCMKTS:CURLF)Stock chart
Graph courtesy of StockCharts.com
From a fundamental standpoint, Curaleaf Holdings Inc. is one of the best – if not the best – cannabis stocks on the market. However, this does not mean that it is not subject to fluctuations. Like most cannabis stocks, CURLF stock has risen over the past year, but it has slipped a bit since peaking in February 2021. Curaleaf shares are currently hovering around their 50-day moving average. For investors who believe in the future of the U.S. cannabis industry, this downturn could be a great opportunity.
curaleaf holdings subsidiariescuraleaf stock forecastjushi holdingscresco labsyahoo financegreen thumb industries,People also search for,Privacy settings,How Search works,Cresco Labs,Medical marijuana company,curaleaf holdings subsidiaries,curaleaf stock forecast,jushi holdings,yahoo finance,green thumb industries,top marijuanas penny stocks 2020,sundial growers